Internal Medicine, Gastroenterology · Tavares, FL
NPI
1952390288
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1703 Mayo Dr
Tavares, FL, 32778
Phone (352) 383-5200
Groups this clinician bills Medicare through
Medicare paid, 2024
$584K
8,807 services
Medicare patients, 2024
2,138
Average age 76
Drug cost, 2024
$1.0M
4,562 prescriptions
Company payments, 2025
$788
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Soundarapandian Baskar was code 88305 (surgical pathology examination), 1,882 times for 641 patients. In total Soundarapandian Baskar billed 8,807 services in 56 codes, and Medicare paid $584K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 1,882 | 641 | $26.19 | $49K |
| 99212 Office E&M - Established | Office | 1,063 | 781 | $40.08 | $43K |
| 88313 Surgical Pathology Examination | Office | 1,046 | 396 | $52.40 | $55K |
| 88312 Surgical Pathology Examination | Office | 691 | 390 | $63.87 | $44K |
| 43239 Upper GI Endoscopy | Facility | 683 | 659 | $62.09 | $42K |
| 99202 Office E&M - New | Office | 489 | 489 | $47.56 | $23K |
| 45385 Colonoscopy - Lesion Removal | Facility | 418 | 417 | $193.57 | $81K |
| 99222 Hospital E&M - Initial | Facility | 415 | 387 | $101.32 | $42K |
| 99213 Office E&M - Established | Office | 344 | 280 | $63.90 | $22K |
| 99232 Hospital E&M - Subsequent | Facility | 313 | 206 | $60.95 | $19K |
| 99211 Office E&M - Established | Office | 265 | 257 | $15.59 | $4,132 |
| 99231 Hospital E&M - Subsequent | Facility | 151 | 122 | $38.69 | $5,843 |
| 45380 Lower GI Endoscopy - Other | Facility | 144 | 144 | $86.49 | $12K |
| 43248 Upper GI Endoscopy | Facility | 140 | 138 | $105.28 | $15K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 140 | 140 | $179.44 | $25K |
By year: 2022 $671K for 9,355 services; 2023 $630K for 9,253 services; 2024 $584K for 8,807 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 1,882 | 641 | $26.19 | $49K |
| 88313 Surgical Pathology Examination | 1,046 | 396 | $52.40 | $55K |
| 88312 Surgical Pathology Examination | 691 | 390 | $63.87 | $44K |
Medicare prescription drug claims, 2024
In 2024, the drug Soundarapandian Baskar prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 825 prescriptions and refills. In total Soundarapandian Baskar wrote 4,562 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 825 | 836 | 814 | $51K |
| Omeprazole Generic | 487 | 960 | 177 | $5,552 |
| Famotidine Generic | 463 | 993 | 176 | $8,555 |
| Dicyclomine Hcl Generic | 358 | 562 | 167 | $9,373 |
| Pantoprazole Sodium Generic | 298 | 610 | 113 | $3,466 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 240 | 251 | 236 | $41K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 214 | 214 | 208 | $3,753 |
| Sucralfate Generic | 155 | 224 | 81 | $6,398 |
| Colestipol Hcl Generic | 153 | 260 | 60 | $8,209 |
| Linzess Linaclotide | 99 | 143 | 34 | $76K |
| Lactulose Generic | 95 | 137 | 61 | $1,871 |
| Creon Lipase/Protease/Amylase | 89 | 117 | 34 | $247K |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 71 | 72 | 70 | $8,745 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 67 | 67 | 65 | $1,423 |
| Ursodiol Generic | 62 | 87 | 13 | $7,185 |
Brand drugs: - claims; generic drugs: 3,533 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Soundarapandian Baskar $788 ($788 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $262.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $262 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $105 |
| Madrigal Pharmaceuticals MDGL | 3 | $89.14 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $77.42 |
| Gilead Sciences, Inc. GILD | 3 | $76.54 |
| Ardelyx, Inc. ARDX | 3 | $53.39 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $45.06 |
| Vivus LLC | 2 | $32.33 |
| Intercept Pharmaceuticals, Inc. | 1 | $16.7 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $15.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.